(Q39387572)

11 September 2017

title

Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner (English)

1 reference

11 September 2017

0 references

Takahiro Osawa

1

1 reference

11 September 2017

Noritaka Ohga

2

1 reference

11 September 2017

Yasuhiro Hida

3

1 reference

11 September 2017

Kazuko Kitayama

4

1 reference

11 September 2017

Kosuke Akiyama

5

1 reference

11 September 2017

Yuichiro Onodera

6

1 reference

11 September 2017

Manabu Fujie

7

1 reference

11 September 2017

Nobuo Shinohara

8

1 reference

11 September 2017

Masanobu Shindoh

9

1 reference

11 September 2017

Katsuya Nonomura

10

1 reference

11 September 2017

Kyoko Hida

11

1 reference

11 September 2017

publication date

17 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

103

1 reference

11 September 2017

issue

6

1 reference

11 September 2017

page(s)

1038-1044

1 reference

Clinical translation of angiogenesis inhibitors

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Antiangiogenesis drug promising for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Tumor-associated endothelial cells with cytogenetic abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Prostacyclin in vascular diseases. - Recent insights and future perspectives -.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Endothelial progenitor cells and angiogenesis join the PPARty

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Angiogenic function of prostacyclin biosynthesis in human endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Peroxisome proliferator-activated receptor alpha is crucial for iloprost-induced in vivo angiogenesis and vascular endothelial growth factor upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Colocalization prostacyclin (PGI2) synthase--caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Prostacyclin receptor up-regulates the expression of angiogenic genes in human endometrium via cross talk with epidermal growth factor Receptor and the extracellular signaling receptor kinase 1/2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

HuR keeps an angiogenic switch on by stabilising mRNA of VEGF and COX-2 in tumour endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Isolated tumor endothelial cells maintain specific character during long-term culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Genes expressed in human tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Prostaglandin I2 promotes recruitment of endothelial progenitor cells and limits vascular remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Adventures in vascular biology: a tale of two mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Molecular cloning of human prostacyclin receptor cDNA and its gene expression in the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

The contributions of cyclooxygenase-2 to tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Inflammation, reproduction, cancer and all that.... The regulation and role of the inducible prostaglandin synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02261.X

Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis

21 January 2018

1 reference

12 December 2020

A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities

1 reference

12 December 2020

Angiogenesis as a predictor of clinical outcome in cancer patients

1 reference

12 December 2020

Heterogeneity of tumor endothelial cells: comparison between tumor endothelial cells isolated from high- and low-metastatic tumors

1 reference

12 December 2020

Prostacyclin among prostanoids.

1 reference

12 December 2020

Cloning and expression of a cDNA for the human prostanoid IP receptor

1 reference

12 December 2020

Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment

1 reference

12 December 2020

Cyclooxygenase in biology and disease

1 reference

12 December 2020

Prognostic significance of morphologic parameters in renal cell carcinoma.

1 reference

12 December 2020

CXCR7: a novel tumor endothelial marker in renal cell carcinoma

1 reference

12 December 2020

Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin

1 reference

12 December 2020

E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer

1 reference

12 December 2020

Stimulation of endothelial cell prostacyclin release by retina-derived factors

1 reference

12 December 2020

Prostaglandin production in phenotypically distinct cultured bovine pulmonary artery endothelium

1 reference

12 December 2020

Angiogenesis inhibitors suffer new setback

1 reference

12 December 2020

Monoclonal antibody drug immunoconjugates for targeted treatment of cancer

1 reference

12 December 2020

10.1111/J.1349-7006.2012.02261.X

Identifiers

DOI

1 reference

11 September 2017

1 reference